Treatment options in acute porphyria, porphyria cutanea tarda, and erythropoietic protoporphyria - PubMed (original) (raw)

Treatment options in acute porphyria, porphyria cutanea tarda, and erythropoietic protoporphyria

Pauline Harper et al. Curr Treat Options Gastroenterol. 2007 Dec.

Abstract

The porphyrias are a group of uncommon metabolic diseases caused by enzyme deficiencies within heme biosynthesis that lead to neurotoxic or phototoxic heme precursor accumulation. There are four acute porphyrias characterized by neuropsychiatric symptoms: acute intermittent porphyria, variegate porphyria, hereditary coproporphyria, and 5-aminolevulinic acid dehydratase deficiency porphyria. Treatment includes elimination of any porphyrogenic factor and symptomatic treatment. Carbohydrate and intravenous heme administration constitute specific therapies in the disorders' acute phase. The mainstay treatment in the cutaneous porphyrias is avoidance of sunlight exposure. In porphyria cutanea tarda and the two acute porphyrias with skin manifestations, variegate porphyria and hereditary coproporphyria, care of the vulnerable skin is important. In porphyria cutanea tarda, specific treatment is accomplished by a series of phlebotomies and/or by low-dose chloroquine administration. In erythropoietic protoporphyria, light-protective beta-carotene is prescribed.

PubMed Disclaimer

Similar articles

• Clinical Guide and Update on Porphyrias.
  Stölzel U, Doss MO, Schuppan D. Stölzel U, et al. Gastroenterology. 2019 Aug;157(2):365-381.e4. doi: 10.1053/j.gastro.2019.04.050. Epub 2019 May 11. Gastroenterology. 2019. PMID: 31085196 Review.
• [Porphyrias].
  Stölzel U, Stauch T, Doss MO. Stölzel U, et al. Internist (Berl). 2010 Dec;51(12):1525-33; quiz 1534. doi: 10.1007/s00108-010-2751-x. Internist (Berl). 2010. PMID: 21104216 Review. German.
• Erythropoietic and hepatic porphyrias.
  Gross U, Hoffmann GF, Doss MO. Gross U, et al. J Inherit Metab Dis. 2000 Nov;23(7):641-61. doi: 10.1023/a:1005645624262. J Inherit Metab Dis. 2000. PMID: 11117426 Review.
• [The cutaneous porphyrias].
  Cuny JF. Cuny JF. Ann Dermatol Venereol. 2019 Feb;146(2):143-159. doi: 10.1016/j.annder.2018.12.005. Epub 2019 Jan 30. Ann Dermatol Venereol. 2019. PMID: 30709634 Review. French.
• [Porphyria].
  Stölzel U, Stauch T, Kubisch I. Stölzel U, et al. Internist (Berl). 2021 Sep;62(9):937-951. doi: 10.1007/s00108-021-01066-1. Epub 2021 Jun 29. Internist (Berl). 2021. PMID: 34185109 Free PMC article. German.

Cited by

• Acute Intermittent Porphyria's Symptoms and Management: A Narrative Review.
  Kizilaslan EZ, Ghadge NM, Martinez A, Bass M, Winayak R, Mathew M, Amin R, Khan M, Kizilbash N. Kizilaslan EZ, et al. Cureus. 2023 Mar 13;15(3):e36058. doi: 10.7759/cureus.36058. eCollection 2023 Mar. Cureus. 2023. PMID: 37065381 Free PMC article. Review.
• Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study.
  Wang B, Ventura P, Takase KI, Thapar M, Cassiman D, Kubisch I, Liu S, Sweetser MT, Balwani M. Wang B, et al. Orphanet J Rare Dis. 2022 Aug 26;17(1):327. doi: 10.1186/s13023-022-02463-x. Orphanet J Rare Dis. 2022. PMID: 36028858 Free PMC article. Clinical Trial.
• Therapeutic RNA-silencing oligonucleotides in metabolic diseases.
  Goga A, Stoffel M. Goga A, et al. Nat Rev Drug Discov. 2022 Jun;21(6):417-439. doi: 10.1038/s41573-022-00407-5. Epub 2022 Feb 24. Nat Rev Drug Discov. 2022. PMID: 35210608 Review.
• In vitro Assessment of Solar Filters for Erythropoietic Protoporphyria in the Action Spectrum of Protoporphyrin IX.
  Sernicola A, Cama E, Pelizzo MG, Tessarolo E, Nicolli A, Viero G, Alaibac M. Sernicola A, et al. Front Med (Lausanne). 2021 Dec 20;8:796884. doi: 10.3389/fmed.2021.796884. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34988101 Free PMC article.
• Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study.
  Ventura P, Bonkovsky HL, Gouya L, Aguilera-Peiró P, Montgomery Bissell D, Stein PE, Balwani M, Anderson DKE, Parker C, Kuter DJ, Monroy S, Oh J, Ritchie B, Ko JJ, Hua Z, Sweetser MT, Sardh E; ENVISION Investigators. Ventura P, et al. Liver Int. 2022 Jan;42(1):161-172. doi: 10.1111/liv.15090. Epub 2021 Nov 16. Liver Int. 2022. PMID: 34717041 Free PMC article. Clinical Trial.

References

1. 1. J Hepatol. 2007 Jan;46(1):174-9 - PubMed
2. 1. J Intern Med. 2003 Aug;254(2):176-83 - PubMed
3. 1. Gut. 2007 Jul;56(7):1009-18 - PubMed
4. 1. Eur J Neurol. 2006 Jun;13(6):668-9 - PubMed
5. 1. Br J Clin Pharmacol. 2007 Nov;64(5):668-79 - PubMed

LinkOut - more resources

• Full Text Sources

  • Springer